These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21444858)

  • 1. Buprenorphine as a safety net for opioid treatment of nonmalignant pain.
    Kornfeld H
    Arch Intern Med; 2011 Mar; 171(6):596-7. PubMed ID: 21444858
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating opioid dependency and coexistent chronic nonmalignant pain.
    Blondell RD; Ashrafioun L
    Am Fam Physician; 2008 Nov; 78(10):1132-3. PubMed ID: 19035061
    [No Abstract]   [Full Text] [Related]  

  • 3. Buprenorphine: considerations for pain management.
    Johnson RE; Fudala PJ; Payne R
    J Pain Symptom Manage; 2005 Mar; 29(3):297-326. PubMed ID: 15781180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term opioid treatment of nonmalignant pain: a believer loses his faith.
    Katz MH
    Arch Intern Med; 2010 Sep; 170(16):1422-4. PubMed ID: 20837826
    [No Abstract]   [Full Text] [Related]  

  • 5. Office-based buprenorphine treatment for opioid-dependent patients.
    McCance-Katz EF
    Harv Rev Psychiatry; 2004; 12(6):321-38. PubMed ID: 15764468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N; Sittl R; Likar R
    Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on Ballantyne and LaForge, Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007;129:235-55.
    Jamison RN; Ross EL; Wasan AD; Michna E
    Pain; 2007 Nov; 132(1-2):218-9; author reply 219. PubMed ID: 17870238
    [No Abstract]   [Full Text] [Related]  

  • 8. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does opiophobia exist among pain specialists?
    Lipman AG
    J Pain Palliat Care Pharmacother; 2004; 18(2):1-5. PubMed ID: 15257971
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C; Failde I; Micó JA; Neira M; Sánchez-Magro I
    Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine use remains hit or miss.
    Miller J
    Behav Healthc; 2014; 34(6):24. PubMed ID: 25774404
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain.
    Tulchinsky A
    Pain; 2007 Nov; 132(1-2):222-3; author reply 223. PubMed ID: 17892914
    [No Abstract]   [Full Text] [Related]  

  • 13. The opioid debate-missing the point.
    Ross E; Jamison R; Edwards R
    J Pain; 2011 Apr; 12(4):508. PubMed ID: 21315661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current pain treatment--no alternative for osteoarthritis patients with severe pain?].
    Dahm P; Karlsson M
    Lakartidningen; 2008 Aug 27-Sep 2; 105(35):2347. PubMed ID: 18831443
    [No Abstract]   [Full Text] [Related]  

  • 15. Transdermal buprenorphine in children with cancer-related pain.
    Attinà G; Ruggiero A; Maurizi P; Arlotta A; Chiaretti A; Riccardi R
    Pediatr Blood Cancer; 2009 Jan; 52(1):125-7. PubMed ID: 18802942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protect your patients, protect your practice: practical risk assessment in the structuring of opioid therapy in chronic pain.
    Fine PG; Finnegan T; Portenoy RK
    J Fam Pract; 2010 Sep; 59(9 Suppl 2):S1-16. PubMed ID: 20824240
    [No Abstract]   [Full Text] [Related]  

  • 18. Pain control battle.
    McCaffery M
    Am J Nurs; 1991 Nov; 91(11):15. PubMed ID: 1683162
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.